Gene mutated in colorectal cancer of humans
US5571905A · kind A · utility
21Cited by
2References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 31, 1994 |
| Grant date | Nov 5, 1996 |
| Priority date | — |
| Expiry date | Mar 31, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/118
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A new human gene termed MCC is disclosed. Methods, primers, probes and kits are provided for assessing mutations of the MCC gene in human tissues and body samples. Gross rearrangement and point mutations in MCC are observed in human tumor cells. MCC is expressed in most normal tissues. These results suggest that MCC is a tumor suppressor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.